Golden Matrix Group, Inc. (OTCPINK: GMGI), formerly known as Source Gold Corp, announced the acquisition of a leading-edge gaming system from Gamefish Global Pty. Ltd., an Australian game development Company specializing in casino games. The acquisition will add value to its diverse portfolio of gaming...
TOMI Environmental Solutions (OTCQB: TOMZ), a Company that offers indoor and outdoor disinfection and decontamination services globally, announced a partnership with Rock Emergency, for the use of its SteraMist line of products, to combat the rapid spread of COVID-19 in the U.S. Rock Environment will...
Fabry Disease also known as angiokeratoma corporis diffusum or alpha-galactosidase A deficiency, is an inherited disorder characterized by the buildup of globotriaosylceramide, a type of fat in the body’s cells and results in numerous disorders such as acroparesthesias (burning, tingling, or prickling sensation in extremities),...
WISekey International Holdings (NASDAQ: WKEY), a premier global cyber security and IOT Company, announced that its plans to showcase the Company’s IoT beacon, which is an ultra-low-power Bluetooth 5 secure beacon, designed for various industrial IoT applications in areas such as cold chain monitoring, heathcare,...
Kannalife Inc (OTCQB: KLFE), a biopharmaceutical Company developing CBD-based therapeutics for the treatment of neurodegenerative and neuropathic pain disorders, announced the grant of a patent Chinese Patent CN106456573B specific to "Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy",...
Melinta Therapeutics (NASDAQ: MLNT), a commercial-stage pharmaceutical Company, engaged in developing therapeutic options for treatment of bacterial infectious diseases, filed for Chapter 11 bankruptcy in January 2020. The Company had concerns about its financial prospects and warned the investors that it would be difficult to...
Inhibitor Therapeutics (OTCQB: INTI), a Biopharmaceutical Company focussed on addressing the unmet medical needs in the field of cancerous and non-cancerous proliferation disorders, announced the receipt of an Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for traconazole, intended for...
Valens GroWorks Corp (OTCQX: VGWCF), a vertically-integrated cannabis player providing extraction products and services, announced the signing of an amended manufacturing and sales licence agreement with SōRSE Technology Corporation for use of its proprietary SōRSE emulsion technology to produce, sell and distribute cannabis-infused products. SōRSE...
According to an estimate by the Centers for Disease Control and Prevention (CDC), SCD affects over 100,000 Americans and is a major public health concern as it resulted in 75,000 hospitalizations between 1989 through 1993, and cost over $475 million. The Medical expenditure of children with...
Lexicon Pharmaceuticals (NASDAQ: LXRX), a biopharmaceutical company leveraging its proprietary Genome5000™ program to develop therapeutics for the treatment of disease such as diabetes, metabolism, oncology and neuropathic pain, announced that the Food and Drug Administration (FDA) has reiterated its rejection of the Company’s New Drug...
